Genzyme receives company award from European Organisation for Rare Diseases
27 February 2013 | By Genzyme
Sanofi and its subsidiary Genzyme announced today that Genzyme has received a Company Award from EURORDIS...
List view / Grid view
27 February 2013 | By Genzyme
Sanofi and its subsidiary Genzyme announced today that Genzyme has received a Company Award from EURORDIS...
19 February 2013 | By Sanofi
Sanofi announced that the U.S. FDA has accepted for review a New Drug Application for lixisenatide...
5 February 2013 | By Sanofi
First and only agent to statistically significantly improve survival in combination with FOLFIRI chemotherapy after an oxaliplatin regimen...
4 February 2013 | By Sanofi
Sanofi portfolio expands to offer first once-a-day prandial GLP-1 receptor agonist...
29 January 2013 | By Sanofi
“Today’s FDA approval of KYNAMRO is great news..."
28 January 2013 | By Sanofi
Genzyme also reports very encouraging early launch indicators for AUBAGIO® (teriflunomide) in U.S.
28 January 2013 | By Sanofi
Auvi-Q is the first-and-only epinephrine auto-injector with audio and visual cues for the emergency treatment of life-threatening allergic reactions...
8 January 2013 | By Sanofi
Sanofi will provide an update on its Research & Development (R&D) pipeline...
7 January 2013 | By Sanofi
“I am delighted that Dr. Gary Nabel will continue to make this Council a vital part of our efforts..."
18 December 2012 | By Sanofi
Sanofi announced that Hanspeter Spek, President, Global Operations, will retire from his current role in mid-2013...
14 December 2012 | By Sanofi
"We are disappointed by the Committee's recommendation..."
9 December 2012 | By Sanofi
New data presented at American Society of Hematology Annual Meeting show activity against disease and symptom alleviation...
3 December 2012 | By Sanofi
American Society of Hematology, Atlanta, GA., 8-11 December, 2012...
28 November 2012 | By Sanofi
Sanofi ranked third among twenty pharmaceutical companies on the 2012 Access to Medicine Index (ATM Index)...
16 November 2012 | By Sanofi
“We are pleased that CHMP has supported our ZALTRAP application..."